180 related articles for article (PubMed ID: 25929524)
1. Medicines for cancers in children: The WHO model for selection of essential medicines.
Robertson J; Magrini N; Barr R; Forte G; Ondari C
Pediatr Blood Cancer; 2015 Oct; 62(10):1689-93. PubMed ID: 25929524
[TBL] [Abstract][Full Text] [Related]
2. Essential medicines for children in Armenia.
Kazaryan I; Vardanyan L
Int J Risk Saf Med; 2015; 27 Suppl 1():S43-4. PubMed ID: 26639704
[TBL] [Abstract][Full Text] [Related]
3. Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders.
Papola D; Ostuzzi G; Todesco B; Gastaldon C; Hanna F; Chatterjee S; van Ommeren M; Barbui C
Lancet Psychiatry; 2023 Oct; 10(10):809-816. PubMed ID: 37475123
[TBL] [Abstract][Full Text] [Related]
4. Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward.
Jenei K; Aziz Z; Booth C; Cappello B; Ceppi F; de Vries EGE; Fojo A; Gyawali B; Ilbawi A; Lombe D; Sengar M; Sullivan R; Trapani D; Huttner BD; Moja L
Lancet Glob Health; 2022 Dec; 10(12):e1860-e1866. PubMed ID: 36183737
[TBL] [Abstract][Full Text] [Related]
5. The selection and use of essential medicines.
WHO Expert Committee
World Health Organ Tech Rep Ser; 2009; (958):1-242, back cover. PubMed ID: 20560299
[TBL] [Abstract][Full Text] [Related]
6. Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain.
Roitberg F; Amaral T; Cherny NI; Giuliani R; Latino NJ; Galotti M; Bricalli G; Curigliano G; Pentheroudakis G; Trapani D
ESMO Open; 2023 Oct; 8(5):101617. PubMed ID: 37672862
[TBL] [Abstract][Full Text] [Related]
7. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
Baxi SM; Beall R; Yang J; Mackey TK
Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
[TBL] [Abstract][Full Text] [Related]
8. Availability of Pediatric Formulations in Public Health Care System in India: A Case Study.
Roy V; Singhal S; Tayal H; Dubey AP
Indian J Pediatr; 2021 Mar; 88(3):227-234. PubMed ID: 32086758
[TBL] [Abstract][Full Text] [Related]
9. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
10. Availability of cytotoxic medicines in the WHO essential medicine list used in treating childhood malignancies in low-income and lower-middle-income countries: a systematic review protocol.
Seneviwickrama M; Gunasekera S; Liyanage G; Heiyanthuduwa W; Jayakody S
BMJ Open; 2023 Jun; 13(6):e071988. PubMed ID: 37336532
[TBL] [Abstract][Full Text] [Related]
11. The selection and use of essential medicines.
WHO Expert Committee
World Health Organ Tech Rep Ser; 2008; (950):backcover, vii-174. PubMed ID: 18754303
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of essential medicines lists: the South African case study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710
[TBL] [Abstract][Full Text] [Related]
13. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
[TBL] [Abstract][Full Text] [Related]
14. Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2017 Jan; 17(1):17. PubMed ID: 28061899
[TBL] [Abstract][Full Text] [Related]
15. Alignment in the registration, selection, procurement and reimbursement of essential medicines for childhood cancers in South Africa.
Joosse IR; van den Ham HA; Mantel-Teeuwisse AK; Suleman F
BMJ Glob Health; 2023 Sep; 8(9):. PubMed ID: 37730243
[TBL] [Abstract][Full Text] [Related]
16. The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).
World Health Organ Tech Rep Ser; 2006; (933):1-119, back cover. PubMed ID: 17566509
[TBL] [Abstract][Full Text] [Related]
17. On Essentiality and the World Health Organization's Model List of Essential Medicines.
Marks VA; Latham SR; Kishore SP
Ann Glob Health; 2017; 83(3-4):637-640. PubMed ID: 29221540
[TBL] [Abstract][Full Text] [Related]
18. Essential medicines for emergency care in Africa.
Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
[TBL] [Abstract][Full Text] [Related]
19. Access to WHO Essential Medicines for Childhood Cancer Care in Trinidad and Tobago: A Health System Analysis of Barriers and Enablers.
Tang B; Bodkyn C; Gupta S; Denburg A
JCO Glob Oncol; 2020 Feb; 6():67-79. PubMed ID: 32031441
[TBL] [Abstract][Full Text] [Related]
20. Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study.
Piggott T; Moja L; Akl EA; Lavis JN; Cooke G; Kredo T; Hogerzeil HV; Huttner B; Alonso-Coello P; Schünemann H
J Clin Epidemiol; 2023 Feb; 154():146-155. PubMed ID: 36584732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]